Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	75.84	75.14	0.16	56.73	68.7
Short-Term Investments	75.41	19.76	32.19	-	-
Cash & Short-Term Investments	151.25	94.9	32.35	56.73	68.7
Cash Growth	59.38%	193.39%	-42.98%	-17.42%	572.76%
Prepaid Expenses	1.06	1.35	0.41	0.42	-
Other Current Assets	0.46	0.4	0.03	1.51	0.04
Total Current Assets	152.77	96.65	32.79	58.66	68.74
Property, Plant & Equipment	0.08	0.07	0.21	0.34	0.19
Long-Term Investments	7.41	-	-	-	-
Other Long-Term Assets	-	-	0.03	0.03	0.03
Total Assets	160.26	96.72	33.03	59.03	68.96
Accounts Payable	1.43	0.19	1.13	0.76	0.51
Accrued Expenses	2.95	4.85	3.96	1.32	1.01
Current Portion of Leases	0.08	0.07	0.13	0.12	0.15
Other Current Liabilities	0.01	0.56	0.06	0.24	0.24
Total Current Liabilities	4.45	5.65	5.28	2.44	1.91
Long-Term Leases	-	-	0.08	0.22	0.07
Other Long-Term Liabilities	-	-	0	-	-
Total Liabilities	4.45	5.65	5.36	2.66	1.98
Common Stock	0	0	0	0	0
Additional Paid-In Capital	450.88	340.78	35	33.11	31.02
Retained Earnings	-295.31	-249.74	-221.87	-191.37	-166.93
Comprehensive Income & Other	0.23	0.03	-0.08	-	-
Total Common Equity	155.81	91.07	-186.95	-158.26	-135.91
Shareholders' Equity	155.81	91.07	27.67	56.37	66.98
Total Liabilities & Equity	160.26	96.72	33.03	59.03	68.96
Total Debt	0.08	0.07	0.21	0.35	0.21
Net Cash (Debt)	158.58	94.83	32.13	56.38	68.49
Net Cash Growth	67.22%	195.11%	-43.01%	-17.68%	593.87%
Net Cash Per Share	5.06	9.07	174.06	459.97	709.34
Filing Date Shares Outstanding	32.2	31.91	22.9	0.12	0.1
Total Common Shares Outstanding	32.2	22.9	0.19	0.12	0.1
Working Capital	148.32	90.99	27.51	56.22	66.83
Book Value Per Share	4.84	3.98	-1010.08	-1291.08	-1407.55
Tangible Book Value	155.81	91.07	-186.95	-158.26	-135.91
Tangible Book Value Per Share	4.84	3.98	-1010.08	-1291.08	-1407.55

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q